From Nasdaq: 2025-06-12 16:34:00

FibroGen, Inc. (FGEN) has announced a 1-for-25 reverse stock split of its common stock, effective June 16, 2025. Trading will begin on a split-adjusted basis on June 17, 2025, under the symbol “FGEN.” The split was approved by stockholders on June 4, 2025, with the final ratio set by the Board of Directors. This action will reduce the number of outstanding shares from about 101.1 million to around 4.0 million.



Read more at Nasdaq: FibroGen To Implement 1-for-25 Reverse Stock Split